These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


402 related items for PubMed ID: 19164452

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.
    Farchoukh L, Kuan SF, Dudley B, Brand R, Nikiforova M, Pai RK.
    Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990
    [Abstract] [Full Text] [Related]

  • 27. CpG island methylator phenotype-positive tumors in the absence of MLH1 methylation constitute a distinct subset of duodenal adenocarcinomas and are associated with poor prognosis.
    Fu T, Pappou EP, Guzzetta AA, Jeschke J, Kwak R, Dave P, Hooker CM, Morgan R, Baylin SB, Iacobuzio-Donahue CA, Wolfgang CL, Ahuja N.
    Clin Cancer Res; 2012 Sep 01; 18(17):4743-52. PubMed ID: 22825585
    [Abstract] [Full Text] [Related]

  • 28. KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients.
    Ye JX, Liu Y, Qin Y, Zhong HH, Yi WN, Shi XY.
    World J Gastroenterol; 2015 Feb 07; 21(5):1595-605. PubMed ID: 25663779
    [Abstract] [Full Text] [Related]

  • 29. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma.
    Bettington M, Walker N, Rosty C, Brown I, Clouston A, McKeone D, Pearson SA, Leggett B, Whitehall V.
    Gut; 2017 Jan 07; 66(1):97-106. PubMed ID: 26475632
    [Abstract] [Full Text] [Related]

  • 30. p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers.
    Bond CE, Umapathy A, Ramsnes I, Greco SA, Zhen Zhao Z, Mallitt KA, Buttenshaw RL, Montgomery GW, Leggett BA, Whitehall VL.
    Int J Cancer; 2012 Apr 01; 130(7):1567-76. PubMed ID: 21557216
    [Abstract] [Full Text] [Related]

  • 31. High frequency of genes' promoter methylation, but lack of BRAF V600E mutation among Iranian colorectal cancer patients.
    Naghibalhossaini F, Hosseini HM, Mokarram P, Zamani M.
    Pathol Oncol Res; 2011 Dec 01; 17(4):819-25. PubMed ID: 21455633
    [Abstract] [Full Text] [Related]

  • 32. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
    Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH.
    Langenbecks Arch Surg; 2011 Oct 01; 396(7):1017-26. PubMed ID: 21706233
    [Abstract] [Full Text] [Related]

  • 33. The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms.
    Borie C, Colas C, Dartigues P, Lazure T, Rince P, Buhard O, Folliot P, Chalastanis A, Muleris M, Hamelin R, Mercier D, Oliveira C, Seruca R, Chadburn A, Leblond V, Barete S, Gaïdano G, Martin A, Gaulard P, Fléjou JF, Raphael M, Duval A.
    Int J Cancer; 2009 Nov 15; 125(10):2360-6. PubMed ID: 19551857
    [Abstract] [Full Text] [Related]

  • 34. IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions.
    Naito T, Nosho K, Ito M, Igarashi H, Mitsuhashi K, Yoshii S, Aoki H, Nomura M, Sukawa Y, Yamamoto E, Adachi Y, Takahashi H, Hosokawa M, Fujita M, Takenouchi T, Maruyama R, Suzuki H, Baba Y, Imai K, Yamamoto H, Ogino S, Shinomura Y.
    World J Gastroenterol; 2014 Aug 07; 20(29):10050-61. PubMed ID: 25110432
    [Abstract] [Full Text] [Related]

  • 35. PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival.
    Rosty C, Young JP, Walsh MD, Clendenning M, Sanderson K, Walters RJ, Parry S, Jenkins MA, Win AK, Southey MC, Hopper JL, Giles GG, Williamson EJ, English DR, Buchanan DD.
    PLoS One; 2013 Aug 07; 8(6):e65479. PubMed ID: 23785428
    [Abstract] [Full Text] [Related]

  • 36. MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes.
    Donehower LA, Creighton CJ, Schultz N, Shinbrot E, Chang K, Gunaratne PH, Muzny D, Sander C, Hamilton SR, Gibbs RA, Wheeler D.
    J Pathol; 2013 Jan 07; 229(1):99-110. PubMed ID: 22899370
    [Abstract] [Full Text] [Related]

  • 37. Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma.
    Su Y, Yin L, Liu R, Sheng J, Yang M, Wang Y, Pan E, Guo W, Pu Y, Zhang J, Liang G.
    Med Oncol; 2014 Feb 07; 31(2):784. PubMed ID: 24366688
    [Abstract] [Full Text] [Related]

  • 38. Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers.
    Svrcek M, Buhard O, Colas C, Coulet F, Dumont S, Massaoudi I, Lamri A, Hamelin R, Cosnes J, Oliveira C, Seruca R, Gaub MP, Legrain M, Collura A, Lascols O, Tiret E, Fléjou JF, Duval A.
    Gut; 2010 Nov 07; 59(11):1516-26. PubMed ID: 20947886
    [Abstract] [Full Text] [Related]

  • 39. Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis.
    Peterson LM, Kipp BR, Halling KC, Kerr SE, Smith DI, Distad TJ, Clayton AC, Medeiros F.
    Int J Gynecol Pathol; 2012 May 07; 31(3):195-205. PubMed ID: 22498935
    [Abstract] [Full Text] [Related]

  • 40. Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features.
    Rosty C, Young JP, Walsh MD, Clendenning M, Walters RJ, Pearson S, Pavluk E, Nagler B, Pakenas D, Jass JR, Jenkins MA, Win AK, Southey MC, Parry S, Hopper JL, Giles GG, Williamson E, English DR, Buchanan DD.
    Mod Pathol; 2013 Jun 07; 26(6):825-34. PubMed ID: 23348904
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.